Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinciane Marchand

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Cancer|November 5, 2014
CD70: A Potential Target in Breast Cancer?Camille Petrau, Marie Cornic, Philippe Bertrand, et al.
Pathology|December 5, 2014
CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinomaFlorian Clatot, Marie Cornic, Anca Berghian, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphomaElodie Bohers, Sylvain Mareschal, Abdelilah Bouzelfen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 19, 2017
Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinomaNicolas Piton, Philippe Ruminy, Claire Gravet, et al.
The Journal of Molecular Diagnostics : JMD|April 21, 2015
Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM StudySylvain Mareschal, Philippe Ruminy, Cristina Bagacean, et al.
American Journal of Hematology|October 14, 2016
Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomasDavid Rizzo, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Oncotarget|March 13, 2015
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?Sydney Dubois, Sylvain Mareschal, Jean-Michel Picquenot, et al.
Blood Advances|February 16, 2021
Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AMLSylvain Mareschal, Anna Palau, Johan Lindberg, et al.
BMC Bioinformatics|March 13, 2021
Improving high-resolution copy number variation analysis from next generation sequencing using unique molecular identifiersPierre-Julien Viailly, Vincent Sater, Mathieu Viennot, et al.
Blood Cancer Journal|May 24, 2020
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphomaVictor Bobée, Fanny Drieux, Vinciane Marchand, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Cancer|November 5, 2014
CD70: A Potential Target in Breast Cancer?Camille Petrau, Marie Cornic, Philippe Bertrand, et al.
Pathology|December 5, 2014
CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinomaFlorian Clatot, Marie Cornic, Anca Berghian, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphomaElodie Bohers, Sylvain Mareschal, Abdelilah Bouzelfen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 19, 2017
Ligation-dependent RT-PCR: a new specific and low-cost technique to detect ALK, ROS, and RET rearrangements in lung adenocarcinomaNicolas Piton, Philippe Ruminy, Claire Gravet, et al.
The Journal of Molecular Diagnostics : JMD|April 21, 2015
Accurate Classification of Germinal Center B-Cell-Like/Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase-Multiplex Ligation-Dependent Probe Amplification Assay: A CALYM StudySylvain Mareschal, Philippe Ruminy, Cristina Bagacean, et al.
American Journal of Hematology|October 14, 2016
Oncogenic events rather than antigen selection pressure may be the main driving forces for relapse in diffuse large B-cell lymphomasDavid Rizzo, Pierre-Julien Viailly, Sylvain Mareschal, et al.
Oncotarget|March 13, 2015
Immunohistochemical and genomic profiles of diffuse large B-cell lymphomas: implications for targeted EZH2 inhibitor therapy?Sydney Dubois, Sylvain Mareschal, Jean-Michel Picquenot, et al.
Blood Advances|February 16, 2021
Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AMLSylvain Mareschal, Anna Palau, Johan Lindberg, et al.
BMC Bioinformatics|March 13, 2021
Improving high-resolution copy number variation analysis from next generation sequencing using unique molecular identifiersPierre-Julien Viailly, Vincent Sater, Mathieu Viennot, et al.
Blood Cancer Journal|May 24, 2020
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphomaVictor Bobée, Fanny Drieux, Vinciane Marchand, et al.
Pageof 2